Estrogen Link to Crohn's Disease Discovered

Image Credit: Scientific Frontline / stock image

Scientific Frontline: Extended "At a Glance" Summary: Estrogen Link to Crohn's Disease

The Core Concept: A disruption in the NOD2 gene, which is critical for immune system activation, causes an unexpected increase in estrogen-related gene activity that drives the gut inflammation and dysfunction characteristic of Crohn's disease.

Key Distinction/Mechanism: While NOD2 mutations have long been associated with Crohn's disease, this research demonstrates that the loss of NOD2 function directly triggers estrogen-driven gut damage. Crucially, exposing healthy models to estrogen replicates this damage, and administering an estrogen receptor inhibitor to NOD2 mutants reverses the intestinal dysfunction.

Major Frameworks/Components:

• NOD2 Gene Mutation: The genetic anomaly responsible for failing to maintain standard gut health and immune response regulation.
• Estrogen Signaling Pathway: The hormonal mechanism that becomes hyperactive in the absence of standard NOD2 function, leading to widespread intestinal lining disruption.
• Zebrafish Modeling: The utilization of whole-organism living models to observe cell-specific gene activity and the interaction among genes, hormones, and immune responses.
• Sex-Biased Immunology: The study addresses a historical data gap where an overreliance on male animal models obscured the estrogen-dependent mechanisms that make females significantly more susceptible to Crohn's disease.

Infectious Disease Pathology: In-Depth Description

Infectious disease pathology is the specialized medical and scientific discipline dedicated to studying the macroscopic, microscopic, and molecular alterations in host tissues caused by infectious agents. Its primary goal is to elucidate the mechanisms of pathogenesis—analyzing how viruses, bacteria, fungi, prions, and parasites invade a host, evade the immune system, and induce structural and functional tissue damage—to inform definitive diagnosis, targeted therapies, and public health interventions.

CellTrap: Lab-on-a-Chip Tracks Immune vs. Cancer Cells

Lead author Muhammad Zia Ullah Khan examines a Petri dish containing a cell suspension. Fluorescence and bright-field images of cells in microchannels, displayed on the monitor, visualize immune cell communication
Photo Credit: Technische Universität München

Scientific Frontline: Extended "At a Glance" Summary: CellTrap Microfluidic Platform

The Core Concept: CellTrap is an instrument-free, microfluidic lab-on-a-chip system designed to isolate and observe interactions between individual immune cells and cancer cells at the single-cell level.

Key Distinction/Mechanism: While conventional laboratory tests measure average values across large cell populations, CellTrap utilizes a continuously branching main channel terminating in 1,024 microscopic trapping chambers. These chambers spatially fix individual cells, allowing researchers to use standard fluorescence time-lapse microscopy to track precise interaction timing, activation signals, and cell death over 14-hour periods.

Major Frameworks/Components:

• Microfluidic Trapping Array: A branching chip architecture containing 1,024 isolated chambers designed to draw in and spatially fix living cells.
• Stochastic Effector-to-Target Observation: The capability to randomly generate and study varying ratios of immune cells to cancer cells within individual chambers.
• Time-Lapse Fluorescence Microscopy: An affordable, standard laboratory imaging method used to track cell-cell interactions over extended observation windows.

What Is: Enteric Nervous System: The Second Brain

Scientific Frontline: Extended "At a Glance" Summary: The Enteric Nervous System (ENS)

The Core Concept: The Enteric Nervous System (ENS) is a highly sophisticated, autonomous network of approximately 500 million neurons and supportive glial cells embedded within the human gastrointestinal tract. Often referred to as the body's "second brain," it operates independently of the central nervous system to govern digestion, mucosal immunity, and systemic physiological homeostasis.

Key Distinction/Mechanism: Unlike traditional peripheral nerves that passively relay brain commands, the ENS acts as an autonomous sensory-motor computing matrix. It detects local physical and chemical stimuli via Intrinsic Primary Afferent Neurons (IPANs), processes this data through complex interneuron circuits, and executes precise muscular and secretory reflexes using over 30 distinct neurotransmitters, including massive quantities of locally synthesized serotonin.

Major Frameworks/Components: 

• The Myenteric Plexus (Auerbach's Plexus): Located deep between the circular and longitudinal muscular layers of the gut, this network primarily orchestrates smooth muscle contraction and the rhythmic phenomena of the peristaltic reflex.
• The Submucosal Plexus (Meissner's Plexus): Situated in the submucosa near the gut lumen, this network regulates localized gastrointestinal secretion, mucosal blood flow, and the selective absorption of water and nutrients.
• Enteric Glial Cells (EGCs): Dynamic, non-neuronal support cells that heavily outnumber neurons. They are indispensable for maintaining the intestinal epithelial barrier, supporting the stem cell niche via WNT ligands, and actively coordinating mucosal immune responses.
• The Gut-Brain Axis (GBA): A bidirectional communication superhighway between the ENS and the central nervous system, primarily utilizing the vagus nerve—which functionally acts as a massive sensory conduit, sending 90% of its data upward to the brain.
• Braak's Hypothesis: A paradigm-shifting neurological framework suggesting that idiopathic Parkinson's disease physically originates in the ENS via misfolded alpha-synuclein proteins, which propagate in a prion-like manner retrogradely up the vagus nerve to the brain.

GALT Immune Cell Mapping & Ulcerative Colitis

Gut-associated lymphoid tissue visualised using imaging mass cytometry.
Image Credit: The Spencer Lab.

Scientific Frontline: Extended "At a Glance" Summary: Gut-Associated Lymphoid Tissue (GALT) Mapping

The Core Concept: Researchers have mapped the precise locations and interactions of immune cells within gut-associated lymphoid tissue (GALT), demonstrating how cellular architecture shifts from preventing inflammation in healthy tissue to driving dysregulation in severe ulcerative colitis.

Key Distinction/Mechanism: Unlike other gut structures that merely act as physical barriers, GALT actively transports gut microbes into the body to train the immune system without triggering inflammation. In healthy GALT, B cells and T cells occupy separate spatial "neighborhoods" to dampen immune responses, whereas in ulcerative colitis, these cells abnormally mix and are displaced from the outer tissue layer.

Major Frameworks/Components:

• Gut-Associated Lymphoid Tissue (GALT): Specialized tissue within the intestinal lining that samples microbes to maintain a stable relationship with beneficial gut bacteria.
• Spatial Transcriptomics & Single-Cell RNA Sequencing: Advanced profiling techniques used to identify which genes are active in specific immune cells and plot their exact microscopic coordinates within the tissue.
• Cellular Neighborhoods: The distinct microenvironments where highly interactive B cells interact with T cells near the tissue's outer layer to suppress inflammation against harmless food proteins and microbes.

Shingles Vaccine Lowers Dementia Risk

Photo Credit: CDC

Scientific Frontline: Extended "At a Glance" Summary: Recombinant Shingles Vaccine (RZV) and Dementia Risk Reduction

The Core Concept: A recent pharmacoepidemiological study indicates that older adults who receive the recombinant shingles vaccine (Shingrix) exhibit a 24% lower risk of being diagnosed with dementia over a four-year period compared to unvaccinated peers.

Key Distinction/Mechanism: Unlike previous observational studies that focused on older live-attenuated vaccines, this research isolates the effects of the newer recombinant zoster vaccine (RZV) on a highly vulnerable demographic entering skilled nursing facilities. While the exact causal mechanism remains unconfirmed, researchers hypothesize the vaccine provides secondary neuroprotective benefits alongside targeted viral suppression.

Major Frameworks/Components:

• Target Trial Emulation: A statistical methodology designed to mimic the conditions and strict parameters of a randomized clinical trial using existing observational health records.
• Pharmacoepidemiology: The application of epidemiological reasoning and methods to study the uses and effects of drugs in well-defined human populations.
• Viral Immunization: The primary function of RZV, preventing the reactivation of the varicella-zoster virus.
• Neuroprotection: The hypothesized secondary outcome of the vaccine, which may help preserve cognitive function and delay the onset of dementia.

IL-10 Autoimmunity: A New Mechanism in IBD

Image Credit: Scientific Frontline / stock image

Scientific Frontline: Extended "At a Glance" Summary: Interleukin-10 Autoimmunity in Inflammatory Bowel Disease

The Core Concept: Inflammatory bowel disease (IBD) is not a singular condition but a group of biologically distinct disorders, with a specific, severe subset driven by an autoimmune response against interleukin-10 (IL-10), a critical regulator of immune homeostasis.

Key Distinction/Mechanism: Unlike general idiopathic intestinal inflammation, this specific pathology is driven by autoantibodies that neutralize IL-10. This loss of inflammatory control is directly mediated by the HLA-DRB1*01:03 genetic variant, providing a definitive mechanistic explanation for one of the strongest known genetic risk factors for IBD.

Major Frameworks/Components:

• Interleukin-10 (IL-10): An essential anti-inflammatory cytokine responsible for maintaining intestinal immune tolerance and keeping mucosal inflammation in check.
• Anti-IL-10 Autoantibodies: Pathogenic antibodies observed in approximately 3.5% of IBD patients (absent in healthy populations) that neutralize the function of IL-10.
• HLA-DRB1*01:03: A specific human leukocyte antigen allele that strongly predisposes individuals to the development of these inflammation-driving autoantibodies.

Germ-Free Zebrafish Microbiome Models

U. of I. pathobiology professor Christopher Gaulke, right, graduate student Lydia Okyere and their colleagues overcame a major hurdle to raising “germ-free” zebrafish beyond the larval stage. Their advance will speed the pace of research into host-microbe interactions.
Photo Credit: Craig Pessman

Scientific Frontline: Extended "At a Glance" Summary: Germ-Free Zebrafish Microbiome Modeling

The Core Concept: A novel husbandry protocol utilizes gamma-irradiated feed to rear germ-free zebrafish beyond their larval phase, establishing the species as a viable, long-term animal model for studying host-microbe interactions.

Key Distinction/Mechanism: Traditional feed sterilization methods, such as autoclaving or ultraviolet radiation, introduce toxic compounds or fail to penetrate the feed surface. Gamma irradiation fully sterilizes the feed without degrading its nutritional profile or introducing harmful byproducts, allowing germ-free zebrafish to survive into juvenile developmental stages.

Major Frameworks/Components:

• Gnotobiotic Animal Models: The use of organisms completely devoid of an endogenous microbiome to isolate and study physiological baselines.
• Gamma Sterilization: The application of ionizing radiation to eliminate microbial life from complex biological matrices, like animal feed, without thermal degradation.
• Transcriptomics and Host Response: Analyzing distinct gene-expression profiles in germ-free subjects, specifically noting the downregulation of pathways related to lipid metabolism, immune function, and xenobiotic metabolism.

What Is: Ebola (Orthoebolavirus zairense)

Ebola virus (species Orthoebolavirus zairense).
Image Credit: CDC

Scientific Frontline: Extended "At a Glance" Summary: Orthoebolavirus zairense (Ebola Virus)

The Core Concept: Orthoebolavirus zairense is a highly sophisticated filovirus that relies on complex molecular evasion, the exploitation of immune-privileged sanctuaries, and the induction of societal disruption to ensure its survival and propagation, challenging its traditional, simplified classification as merely an agent of acute hemorrhagic fever.

Key Distinction/Mechanism: Unlike pathogens that trigger immediate immune clearance, this virus actively subverts the human immune system through RNA editing (overproducing the sGP protein to hijack antibody responses) and establishes long-term chronicity by physically breaking down cellular barriers to hide in the central nervous system, eyes, and testes.

Origin/History: The virus maintains a peaceful evolutionary truce within its natural chiropteran (bat) reservoir. Bats harbor the virus asymptomatically due to an evolutionary genomic mutation (S358) in their STING pathway, which dampens their inflammatory response to accommodate the severe metabolic demands of flight.

Unlocking Durable Immunotherapy with Stem Cell-Derived CD4⁺ T Cells

Image Credit: Courtesy of Center for iPS Cell Research and Application

Scientific Frontline: Extended "At a Glance" Summary: Stem Cell-Derived CD4⁺ T Cell Immunotherapy

The Core Concept: Stem cell-derived CD4⁺ T cell immunotherapy is a novel approach to cancer treatment that differentiates human induced pluripotent stem (iPS) cells into adaptive-like CD4⁺ T cells equipped with chimeric antigen receptors (CARs) to target and destroy malignancies.

Key Distinction/Mechanism: While traditional CAR-T therapies rely heavily on CD8⁺ T cells that often suffer from rapid functional exhaustion, CD4⁺ T cells uniquely resist this decline. They maintain long-term proliferation, secrete immune-coordinating cytokines, and act as direct cytotoxic effectors across repeated rounds of antigen exposure.

Major Frameworks/Components:

• Induced Pluripotent Stem (iPS) Cells: A renewable, highly scalable, and genetically malleable source material intended for "off-the-shelf" immune cell manufacturing.
• Artificial Thymic Organoid System: A specialized developmental model used to successfully differentiate iPS cells into mature, adaptive-like T cells rather than innate-like lymphocytes.
• Chimeric Antigen Receptor (CAR) Engineering: Genetic modifications (such as CD19-targeting) that enable the CD4⁺ T cells to specifically recognize and eliminate leukemia cells.
• Memory-Like Molecular Signature: An intrinsic genetic programming profile that grants the engineered CD4⁺ cells resistance to functional decline over time.

Living Bandage: Accelerating Wound Healing

Wound-healing patches can vary in size and present indentations housing cytokine-secreting cells (right). In preclinical studies, delivery of cytokines using the patch supported accelerated wound healing.
Photo Credit: Jared Jones/Rice University

Scientific Frontline: Extended "At a Glance" Summary: Living Bandage (Cytokine Factory Patch)

The Core Concept: The living bandage is a cell-based delivery platform that utilizes encapsulated, engineered cells as on-site "factories" to secrete therapeutic signaling proteins directly into a wound over extended periods. It is designed to maintain therapeutic levels of tissue-regenerating molecules precisely where they are needed most.

Key Distinction/Mechanism: Unlike conventional cytokine delivery approaches that are limited by rapid degradation and poor retention at the wound site, this system provides sustained, localized immunomodulation. Engineered ARPE-19 cells are housed within a biocompatible hydrogel matrix that allows nutrients to enter and therapeutic proteins to exit, all while shielding the active cells from the host's immune system.

Major Frameworks/Components: 

• Engineered ARPE-19 Cells: Cells genetically modified to continuously secrete specific healing cytokines, including IL-10, IL-12, and TGF-β.
• Biocompatible Hydrogel Matrix: A protective casing that isolates the therapeutic cells from the host immune system while remaining permeable to nutrients and secreted proteins.
• Transcriptomic Validation: The activation of key wound-healing pathways and upregulation of tissue regeneration genes were validated through RNA sequencing.
• Modular Platform: The system can be adapted to produce different combinations of growth factors or integrated with bioelectronic components for specific clinical applications.

Immune Treatments for Severe Valley Fever

Very high magnification micrograph of coccidioidomycosis, also known as valley fever and California disease. GMS stain.
Image Credit: Nephron
(CC BY-SA 3.0)

Scientific Frontline: Extended "At a Glance" Summary: Valley Fever Immune Modulation

The Core Concept: Valley Fever (Coccidioidomycosis) is a severe dust-borne fungal infection, and recent studies reveal that life-threatening, disseminated cases can be successfully treated by modulating the patient's immune system.

Key Distinction/Mechanism: Unlike traditional treatments that attack the fungus directly with antifungal drugs, this approach corrects an abnormal immune response by either reversing T cell exhaustion or realigning a misdirected "Type 2" allergic immune reaction.

Major Frameworks/Components:

• T Cell Exhaustion: A weakened immune state where cells burn out from constant fungal exposure, marked by elevated levels of the PD-1 protein acting as a "brake" on the immune system.
• Type 2 Immune Skewing: An abnormal physiological response, found almost exclusively in males, where the body mistakenly interprets the fungal infection as an allergy or parasite.
• Therapeutic Modulation: The use of targeted medications—such as interferon gamma to reinvigorate T cells or the allergy drug dupilumab to reverse Type 2 skewing—to retune the body's natural defenses.

RSV Genetic Mutations and Severity

Human Respiratory Syncytial Virus (RSV) 3D rendering of respiratory syncytial virus (RSV)—a common contagious virus that infects the human respiratory tract—colorized in Halloween-appropriate colors (the viral envelope is purple, G- glycoproteins are light blue, and F-glycoproteins are orange). F-glycoproteins allow the virus to fuse with and infect human cells.
Image Credit: National Institute of Allergy and Infectious Diseases

Scientific Frontline: Extended "At a Glance" Summary: RSV Genetic Mutations

The Core Concept: Researchers have identified 19 specific genetic mutations in the Respiratory Syncytial Virus (RSV) that trigger significantly faster viral replication and lead to more severe illness in pediatric patients.

Key Distinction/Mechanism: Unlike typical RSV strains that cause mild cold-like symptoms, these mutated variants replicate 10 to 100 times faster due to genetic changes in viral replication mechanisms, resulting in higher viral loads and greater virulence.

Major Frameworks/Components: 

• Genomic comparison between mild and severe pediatric clinical samples to isolate exact mutation profiles.
• In vitro laboratory culturing to quantify viral replication rates and measure virulence.
• Ongoing surveillance to determine if newly introduced RSV vaccines for mothers and newborns exert evolutionary pressure on the virus.
• Expansion of research into adult demographics to study how comorbidities interact with these viral mutations.

Psychoneuroimmunology: In-Depth Description

Psychoneuroimmunology (PNI) is the interdisciplinary study of the complex, bidirectional interactions between the central nervous system, the endocrine system, the immune system, and psychological processes. The primary goal of this field is to elucidate how mental states, emotional stress, and behavioral factors modulate immune function and susceptibility to disease, as well as how systemic immune activity can alter neural circuitry, mood, and behavior.

RELA Gene Boundary & Rare Inflammatory Disease

Scientists identified a key breakpoint in the RELA gene that helps predict how harmful mutations cause a rare inherited inflammatory disease. Mutations in a location before amino acid P290 reduce protein levels, while those located after P290 produce disruptive proteins. The finding could improve diagnosis and treatment selection for patients with RELA deficiency.
Image Credit: Hiroko Hayakawa/Hiroshima University

Scientific Frontline: Extended "At a Glance" Summary: The RELA Gene Boundary Discovery

The Core Concept: Researchers have identified a critical structural boundary within the immune-regulating gene RELA—specifically at amino acid proline 290 (P290)—that dictates how genetic mutations manifest in patients with a rare inherited inflammatory disease.

Key Distinction/Mechanism: Mutations occurring before the P290 boundary result in haploinsufficiency (a harmful shortage of functional protein). Conversely, mutations occurring after P290 cause a dominant-negative effect, where an abnormal, shortened protein actively interferes with normal cellular function and triggers more severe inflammation.

Major Frameworks/Components:

• Autosomal Dominant RELA Deficiency: A rare genetic condition characterized by recurrent ulcers, intestinal inflammation, and broader autoinflammatory symptoms.
• Haploinsufficiency vs. Dominant-Negative Effect: The two distinct pathological pathways determined by the genetic mutation's physical location relative to the P290 breakpoint.
• Stop Codons: Premature nucleotide sequences that terminate protein synthesis, driving the specific type of molecular failure depending on where they occur.

MouseMapper: AI Analyzes Bodies at the Cell Level

Whole-Body Analysis
MouseMapper automatically segments 31 organs and tissue types in a mouse while simultaneously mapping neural and immune cells throughout the body. This enables comprehensive multi-organ analyses in intact mice.
Image Credit: © Ertürk Lab | Helmholtz Munich

Scientific Frontline: Extended "At a Glance" Summary: MouseMapper AI-Powered Whole-Body Analysis

The Core Concept: MouseMapper is an advanced, AI-powered imaging and analytical system that enables the whole-body analysis of mice down to the single-cell level. It automatically maps neural pathways, immune cells, and organs to visualize pathological changes throughout the entire organism.

Key Distinction/Mechanism: Unlike classical AI systems built for single tasks, MouseMapper utilizes "foundation models"—large AI models trained on vast datasets to recognize general patterns. Combined with tissue clearing and light-sheet microscopy, this deep learning framework flexibly adapts to various datasets to systematically compare changes across 31 different organs and tissues.

Major Frameworks/Components: 

• Tissue Clearing and Light-Sheet Microscopy: Imaging techniques utilized to process and visualize the complex anatomy of the organism at high resolutions.
• Foundation Models: Deep learning AI structures trained to recognize generalized patterns, allowing the flexible mapping of the finest nerve structures and immune cell accumulations.
• Molecular Analysis Integration: The system flags conspicuous regions for further molecular examination to connect cellular damage to specific signaling pathways.

Immunotherapy for Depression: A New Trial

Pilot trial suggests anti-inflammatory drug could help difficult-to-treat depression
Photo Credit: Anna Shvets

Scientific Frontline: Extended "At a Glance" Summary: Immunotherapy for Difficult-to-Treat Depression

The Core Concept: A recent pilot clinical trial indicates that tocilizumab, an existing anti-inflammatory drug, shows promise in alleviating symptoms for patients with difficult-to-treat depression. By treating depression as an immune-related condition rather than solely a neurochemical one, this approach offers a new therapeutic avenue for those unresponsive to standard medications.

Key Distinction/Mechanism: Unlike traditional antidepressants that target brain chemicals like serotonin and dopamine, this treatment blocks the interleukin-6 (IL-6) inflammatory pathway. This mechanism specifically targets the estimated one-in-three depressed patients who exhibit signs of an overactive immune system and low-grade inflammation in their blood.

Origin/History: The University of Bristol-led pilot randomized controlled trial was published in JAMA Psychiatry on May 20, 2026. The trial was built upon foundational genetic research utilizing Mendelian randomization, which previously established a causal link between the IL-6 cytokine and depression.

Cytokine-Armored CAR-T Fights Glioblastoma

Image Credit: Scientific Frontline

Scientific Frontline: Extended "At a Glance" Summary: Cytokine-Armored CAR-T Cell Therapy

The Core Concept: Cytokine-armored CAR-T cell therapy is a novel cancer treatment that reprograms engineered T-cells to not only target cancer but also release immune-stimulating proteins. This dual action activates the body's natural immune system to strengthen the overall anti-cancer response against aggressive brain tumors like glioblastoma.

Key Distinction/Mechanism: Traditional CAR-T therapies often fail against solid tumors because they can only kill cells presenting a specific antigen. The "armored" approach bypasses this limitation by secreting cytokines (IL-12 and DR-18) that recruit a massive influx of diverse, naturally occurring immune cells into the brain. This allows the immune system to eradicate heterogeneous tumor cells that lack the primary CAR-T target. Additionally, a secondary CAR-T strategy targeting VEGF is utilized to minimize dangerous treatment-related inflammation.

Origin/History: Developed by researchers at the UCLA Health Jonsson Comprehensive Cancer Center, led by Dr. Yvonne Chen and doctoral student Justin Clubb, the preclinical success of this therapy was published in the journal Cancer Research in May 2026.

ALS Chain Reaction: How Inflammation Drives Progression

Study links TDP‑43 pathology to inflammation, disease progression and survival across ALS subtypes
Image Credit: Scientific Frontline / stock image

Scientific Frontline: Extended "At a Glance" Summary: ALS Pathological Chain Reaction

The Core Concept: Amyotrophic lateral sclerosis (ALS) progresses through a sequential, domino-like cascade that begins with early cellular breakdown inside motor neurons and is subsequently amplified by a damaging inflammatory immune response in the bloodstream and spinal cord.

Key Distinction/Mechanism: Rather than causing the initial onset of ALS, the body's inflamed immune cells react to the initial nerve pathology and act as a disease amplifier. The intensity of this spinal cord inflammation determines the speed of disease progression and overall survival duration, not whether a patient develops ALS in the first place.

Major Frameworks/Components:

• TDP-43 Pathology: The hallmark toxic protein buildup and dysfunction inside motor neurons that initiates the degenerative cascade.
• Spatial Transcriptomics: An advanced technique utilized by the researchers to pinpoint the exact locations of heightened immune gene activity directly surrounding motor neuron loss in postmortem spinal tissue.
• Single-Cell RNA Sequencing: A technology deployed to profile inflamed immune cells and elevated complement gene expression in the blood samples of living patients.

‘Garbage collectors’ of the brain grind to a halt in fatal disease

Scientific Frontline: Extended "At a Glance" Summary: Multiple System Atrophy (MSA)

The Core Concept: Multiple system atrophy (MSA) is a rare, aggressive, and fatal neurological disorder that attacks the autonomic nervous system, severely impacting balance, movement, and critical bodily functions.

Key Distinction/Mechanism: While MSA clinically resembles Parkinson's disease, it typically strikes earlier and progresses much more rapidly; recent research indicates this accelerated decline is linked to microglia (the brain's immune cells) becoming severely exhausted and failing to clear away toxic cellular waste.

Major Frameworks/Components:

• Microglia Dysfunction: The immune cells of the brain lose their ability to act as cellular "garbage collectors," allowing accumulated proteins and dying cells to damage the nervous system.
• Single-Cell RNA Sequencing: An advanced genetic sequencing method utilized to map active genes within individual cell nuclei from the striatum of deceased patients.
• Immune Overactivation Theory: A prevailing hypothesis suggesting the immune system is hyperactive in the disease's early stages, leading to total cellular exhaustion in the later stages.